MJ

Murugesan Jayabalan

Director Director DIN 02456615
DIN 02456615 First appointment Dec 2001 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2001
Shareholding value Locked Premium profile

About Murugesan Jayabalan

Data last updated:

Murugesan Jayabalan has 24 years in corporate governance. Formerly with 1 company, such as Apharmo Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02456615
Primary Designation Director
First Appointment 14 Dec 2001
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Apharmo Limited U24231TN1993PLC025375
Director14 Dec 20011993Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apharmo Limited
Premium access

Shareholding and investment profile for Murugesan Jayabalan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murugesan Jayabalan

Murugesan Jayabalan has 24 years in corporate governance. Formerly with 1 company, such as Apharmo Limited. Engaged in General Business. Contributes to corporate operations.

Murugesan Jayabalan is associated with 0 companies as a director.

Murugesan Jayabalan has expertise in General Business.

Murugesan Jayabalan has 24 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available